Role of microRNAs in fibrosis

Open Rheumatology Journal

Volumn 6, Issue 1, 2012, Pages 130-139

  Vettori, Serena ^a,b   Gay, Steffen ^a   Distler, Olive ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antagomirs; Connective tissue growth factor (CTGF); Epithelial to mesenchymal transition (EMT); Extracellular matrix (ECM); Fibroblasts; Fibrosis; Microrna (miRNA) mediated gene regulation regulation; Signaling pathways; Transforming growth factor beta (TGF )

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MICRORNA; MICRORNA 107; MICRORNA 132; MICRORNA 133; MICRORNA 141; MICRORNA 150; MICRORNA 155; MICRORNA 15B; MICRORNA 16; MICRORNA 17 92; MICRORNA 18A; MICRORNA 192; MICRORNA 199A; MICRORNA 199B; MICRORNA 19A; MICRORNA 19B; MICRORNA 200A; MICRORNA 204; MICRORNA 208; MICRORNA 21; MICRORNA 216; MICRORNA 217; MICRORNA 29; MICRORNA 30; MICRORNA 30C; MICRORNA 377; MICRORNA 590; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

DISEASE ASSOCIATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROGENESIS; FIBROSIS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84863930652     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901206010130     Document Type: Review

References (91)

1. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2007; 214: 199-210.
2. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117: 524-9.
3. Zimmer V, Lammert F. Genetics in liver disease: new concepts. Curr Opin Gastroenterol 2011; 27: 231-9.
4. Romano E, Manetti M, Guiducci S, Ceccarelli C, Allanore Y, Matucci CM. The genetics of systemic sclerosis: an update. Clin Exp Rheumatol 2011; 29: S75-86.
5. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002; 3: 349-63.
6. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006; 8: 145-50.
7. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-84.
8. Mehal WZ, Iredale J, Friedman SL. Scraping fibrosis. Nat Med 2011; 17: 552-3.
9. Chau BN, Brenner DA. What goes up must come down: the emerging role of microRNA in fibrosis. Hepatology 2011; 53: 4-6.
10. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18: 510-25.
11. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-50.
12. van Rooji E, Olson EN. Searching for MIR-acles in cardiac fibrosis. Circ Res 2009; 104: 138-40.
13. Jiang X, Tsitsiou E, Herrick SE, Lindsay M. MicroRNAs and the regulation of fibrosis. FEBS J 2010; 277: 2015-21.
14. Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011; 157: 191-9.
15. Lorenzen JM, Haller H, Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 2011; 7: 286-94.
16. Wei J, Bhattacharyya S, Tourtellotte WG, Varga J. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 2011; 10: 267-75.
17. Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol 2011; 25: 281-90.
18. Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanisms of cardiac fibrosis. J Cell Physiol 2010; 225: 631-7.
19. Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011; 89: 265-82.
20. Dussaule JC, Guerrot D, Huby AC, et al. The role of cell plasticity in progression and reversal of renal fibrosis. Int J Exp Pathol 2011; 92: 151-7.
21. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339-50.
22. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
23. Kozomara A, Griffiths JS. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-7.
24. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
25. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102-14.
26. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318: 1931-4.
27. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33.
28. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11: 252-63.
29. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 2007; 35: D149-55.
30. Chen CY, Chen ST, Fuh CS, Juan HF, Huang HC. Coregulation of transcription factors and microRNAs in human transcriptional regulatory network. BMC Bioinformatics 2011; 12: S41.
31. Vrba L, Garbe JC, Stampfer MR, Futscher BW. Epigenetic regulation of normal human mammary cell type specific miRNAs. Genome Res 2011; 21: 2026-37.
32. Lee S, Jung JW, Park SB, et al. Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord bloodderived multipotent stem cell aging. Cell Mol Life Sci 2011; 68: 325-36.
33. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad protein bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010; 39: 373-84.
34. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010; 5: e10615.
35. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumor biology. Nature 2010; 465: 1033-40.
36. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötval JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9.
37. Varga J, Denton CP. Scleroderma, inflammatory myopathies, and overlap syndromes. In: Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS, Eds. Kelley's Textbook of Rheumatology. 8th ed. USA: Saunders Elsevier 2009; 1311-51.
38. Markiewicz M, Smith EA, Rubinchik S, Dong JY, Trojanowska M, LeRoy EC. The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts. Clin Exp Rheumatol 2004; 22: S31-4.
39. Hasegawa M, Fujimoto M, Takehara K, Sato S. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 2005; 39: 1-7.
40. Garabrant DH, Lacey JV Jr, Laing TJ, et al. Scleroderma and solvent exposure among women. Am J Epidemiol 2003; 157: 493-500.
41. Varga J, Haustein UF, Creech RH, Dwyer JP, Jimenez SA. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA 1991; 265: 3292-5.
42. Ishida W, Mori Y, Lakos J, et al. Intracellular TGF-blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo. J Invest Dermatol 2006; 126: 1733-44.
43. Pannu J, Gore HE, Yamanaka M, et al. An increased transforming growth factor receptor type I: type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinasedeficient transforming growth factor receptor type II in scleroderma. Arthritis Rheum 2004; 50: 1566-77.
44. Svegliati S, Cancello R, Sambo P, et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate RAS protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and RAS in systemic sclerosis fibroblasts. J Biol Chem 2005; 280: 36474-82.
45. Bergmann C, Akhmetshina A, Dees C, et al. Inhibition of glycogen synthase kinase3{beta} induces dermal fibrosis by activation of the canonical Wnt pathway. Ann Rheum Dis 2011; 70: 2191-8.
46. Dees C, Akhmetshina A, Zerr P, et al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 2011; 208: 961-72.
47. Maurer B, Stanczyck J, Jungel A, et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 2010; 62: 1733-43.
48. Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 182: 220-9.
49. Scian MJ, Maluf DG, David KG, et al. MicroRNA profiles in allograft tissues and paired urine associate with chronic allograft dysfunction with IF/TA. Am J Transplant 2011; 11: 2110-22.
50. Katare R, Riu F, Mitchell K, et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011; 109: 894-906.
51. Mann J, Chu DC, Maxwell A, et al. MeCP2 controls an epigenetic pathway that promotes myofibroblasts transdifferentiation and fibrosis. Gastroenterology 2010; 138: 705-14.
52. Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009; 104: 170-8.
53. Shan H, Zhang Y, Lu Y, et al. Down-regulation of miR-133 and miR-590 contributes to atrial remodelling in canines. Cardiovasc Res 2009; 83: 465-72.
54. Wang B, Koh P, Winbanks C, et al. miR-200a prevents renal fibrogenesis through repression of TGF-2 expression. Diabetes 2011; 60: 280-7.
55. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 2009; 50: 766-78.
56. Ezzie ME, Crawford M, Choo JH, et al. Gene expression network in COPD: microRNA and mRNA regulation. Thorax 2012; 67: 122-31.
57. Venugopal SK, Jiang J, Kim TH, et al. Liver fibrosis causes downregulation of miR-150 and miR-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 2010; 298: G101-6.
58. Pottier N, Maurin T, Chevalier B, et al. Indentification of keratinocyte growth factor as a target of miR-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009; 4: e6718.
59. Pogribny IP, Starlard DA, Tryndyak VP, et al. Difference in expression of hepatic miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 2010; 90: 1437-46.
60. Kodama T, Takehara T, Hikita H, et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest 2011; 121: 3343-56.
61. van Almen GC, Verhesen W, van Leeuwen RE, et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in agerelated heart failure. Aging Cell 2011; 10: 769-79.
62. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007; 104: 3432-7.
63. Wang B, Herman EM, Koh P. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 2010; 59: 1794-802.
64. da Costa Martins PA, Salic K, et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto amplification-loop promoting calcineurin-NFAT signaling. Nat Cell Biol 2010; 12: 1220-7.
65. Murakami Y, Toyoda H, Tanaka M, et al. The progression of liver fibrosis is related to overexpression of miR-199 and miR-200 families. PLoS One 2011; 6: e16081.
66. Oba S, Kumano S, Suzuki E, et al. miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS One 2010; 5: e13614.
67. van Rooji E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007; 316: 575-9.
68. Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010; 207: 1589-97.
69. Thum T, Gross C, Fiedler J, et al. MIcroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-4.
70. Zhong X, Chung AC, Chen XY, Meng XM, Lan HY. Smad3-mediated up-regulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011; 22: 1668-81.
71. Kato M, Putta S, Wang M, et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11: 881-9.
72. Cho JH, Gelinas R, Wang K, et al. Systems biology of interstitial lung disease: mRNA and microRNA expression changes. BMC Med Genomics 2011; 4: 8.
73. Ji J, Zhang J, Huang G, Qian J, Wang X, Mei S. Over-expressed miRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009; 583: 759-66.
74. van Rooji E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of mIR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008; 105: 13027-32.
75. Cushing L, Kuang PP, Qian J, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011; 45: 287-94.
76. Liu Y, Taylor NE, Lu L, et al. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 2010; 55: 974-82.
77. Du B. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 2010; 584: 811-6.
78. Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 2011; 317: 1714-25.
79. Zhang H, Liu X, Chen S, et al. Tectorigenin inhibits the in vitro proliferation and enhances miR-338* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis. J Ethnopharmacol 2010; 131: 165-73
80. Li WQ, Chen C, Xu MD, et al. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 2011; 278: 1522-32.
81. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008; 22: 4126-35.
82. Kriegel AJ, Fang Y, Liu Y, et al. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor 1: a novel role of miR-382. Nucleic Acids Res 2010; 38: 8338-47.
83. Muth M, Theophile K, Hussein K, Jacobi C, Kreipe H, Bock O. Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE-1 (PAI-1) mRNA-a mechanism involved in SERPINE-1 (PAI-1) overexpression. J Transl Med 2010; 8: 33.
84. Nicolas FE. Experimental validation of microRNA targets using a luciferase reporter system. Methods Mol Biol 2011; 732: 139-52.
85. Santibanez JF, Quintanilla M, Bernabeu C. TGF-/TGF-receptor system and its role in physiological and pathological conditions. Clin Sci 2011; 121: 233-51.
86. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006; 119: 4803-10.
87. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Gen 2006; 38: 1060-5.
88. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
89. Kumarswamy R, Volkmann I, Thum T. Regulation and function of miR-21 in health and disease. RNA Biol 2011; 8: 1-8.
90. Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010; 120: 3912-6.
91. Broderick JA, Zamore D. MicroRNA therapeutics. Gene Ther 2011; 18: 1104-10.